34-39 of 39 results for ophthalmology
| Formulation | Classification | Strength |
|---|---|---|
| Prednisolone-Acetate PF* – 5mL | Topical Medication | 1% |
| Tim-Brim-Dor-Lat® (Timolol/Brimonidine/Dorzolamide/Latanoprost) PF* – 5mL | Topical Medication | 0.5/0.15/2/0.005% |
| Tim-Brim-Dor® PF (Timolol/Brimonidine/Dorzolamide)* – 10mL | Topical Medication | 0.5/0.15/2% |
| Tim-Dor-Lat® (Timolol/Dorzolamide/Latanoprost) PF* – 5mL | Topical Medication | 0.5/2/0.005% |
| Tim-Lat® (Timolol/Latanoprost) PF* – 5mL | Topical Medication | 0.5%/0.005% |
| Tri-Moxi®* – 0.6mL – Single Use Vial | Injectable | 15mg/1mg/mL |
*For professional use only. ImprimisRx® Pharmacy specializes in customizing medications to meet unique patient and practitioner needs. ImprimisRx® dispenses only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.
Potential Ingredient Risks
Possible Indications: Postoperative Inflammation, Blepharitis, Allergic Conjunctivitis, Catarrhal Corneal Ulcer, Conjunctival Infection, Corneal Injury, Keratoconjunctivitis, Superficial Keratitis, Vernal Conjunctivitis
Possible Adverse Effects: Accommodation Disturbance, Anterior Uveitis, Blepharitis, Conjunctival Hyperemia, Conjunctivitis, Corneal Perforation or Ulcer, Decreased Visual Acuity, Eye Infection, Glaucoma, Increased Intraocular Pressure, Keratitis, Mydriasis, Optic Nerve Damage, Visual Field Defect, Wound Healing Impairment
Potential Contraindications/Precautions: Infants, Lactation, Pregnancy.
Storage: Store at Room Temperature, 20°C to 25°C (68°F to 77°F)
Auxiliary Labeling: Store upright in original bottle, Protect from light, Shake well before use.